BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21982575)

  • 21. Ontogenic expression profiles of thyroid-specific genes in embryonic and hatching chicks.
    Grommen SV; Iwasawa A; Beck V; Darras VM; De Groef B
    Domest Anim Endocrinol; 2011 Jan; 40(1):10-8. PubMed ID: 20926227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroperoxidase and Na+/I- symporter mRNAs in dog thyroid.
    Uyttersprot N; Pelgrims N; Carrasco N; Gervy C; Maenhaut C; Dumont JE; Miot F
    Mol Cell Endocrinol; 1997 Aug; 131(2):195-203. PubMed ID: 9296378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential changes in serum thyroid peroxidase following radioiodine therapy of patients with differentiated thyroid carcinoma.
    Ozata M; Bayhan H; Bingöl N; Dündar S; Beyhan Z; Corakci A; Gundogan MA
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3634-8. PubMed ID: 8530612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Transfection of follicular thyroid gland carcinoma cells with human TSH receptor changes growth, invasion and adhesion].
    Hoelting T; Duh QY; Clark OH; Herfarth C
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):281-4. PubMed ID: 14518260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line.
    Jeong H; Kim YR; Kim KN; Choe JG; Chung JK; Kim MK
    Nucl Med Biol; 2006 Oct; 33(7):875-82. PubMed ID: 17045167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
    Mitrofanova E; Unfer R; Vahanian N; Link C
    Gene Ther; 2006 Jul; 13(13):1052-6. PubMed ID: 16525480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of miR-146b expression increases radioiodine-sensitivity in poorly differential thyroid carcinoma via positively regulating NIS expression.
    Li L; Lv B; Chen B; Guan M; Sun Y; Li H; Zhang B; Ding C; He S; Zeng Q
    Biochem Biophys Res Commun; 2015 Jul; 462(4):314-21. PubMed ID: 25960292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells.
    Chai W; Ye F; Zeng L; Li Y; Yang L
    J Exp Clin Cancer Res; 2019 Jul; 38(1):325. PubMed ID: 31331356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of the optimal time for radioiodine therapy in anaplastic thyroid carcinoma using the adenovirus-mediated transfer of sodium iodide symporter gene.
    So Y; Lee YJ; Lee WW; Chung JK
    Oncol Rep; 2013 Apr; 29(4):1666-70. PubMed ID: 23404348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined RNA interference of hexokinase II and (131)I-sodium iodide symporter gene therapy for anaplastic thyroid carcinoma.
    Kim JE; Ahn BC; Hwang MH; Jeon YH; Jeong SY; Lee SW; Lee J
    J Nucl Med; 2011 Nov; 52(11):1756-63. PubMed ID: 21994409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of thyrotropin receptor (TSH-R), thyroglobulin, thyroperoxidase, and calcitonin messenger ribonucleic acids in thyroid carcinomas: evidence of TSH-R gene transcript in medullary histotype.
    Elisei R; Pinchera A; Romei C; Gryczynska M; Pohl V; Maenhaut C; Fugazzola L; Pacini F
    J Clin Endocrinol Metab; 1994 Apr; 78(4):867-71. PubMed ID: 8157713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioiodine 131I treatment for large nodular goiter: recombinant human thyrotropin allows the reduction of radioiodine 131I activity to be administered in patients with low uptake.
    Ceccarelli C; Antonangeli L; Brozzi F; Bianchi F; Tonacchera M; Santini P; Mazzeo S; Bencivelli W; Pinchera A; Vitti P
    Thyroid; 2011 Jul; 21(7):759-64. PubMed ID: 21568727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recovery of NIS expression in thyroid cancer cells by overexpression of Pax8 gene.
    Presta I; Arturi F; Ferretti E; Mattei T; Scarpelli D; Tosi E; Scipioni A; Celano M; Gulino A; Filetti S; Russo D
    BMC Cancer; 2005 Jul; 5():80. PubMed ID: 16029487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
    Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
    Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer.
    Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M
    Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium/iodide symporter (NIS) gene expression is the limiting step for the onset of thyroid function in the human fetus.
    Szinnai G; Lacroix L; Carré A; Guimiot F; Talbot M; Martinovic J; Delezoide AL; Vekemans M; Michiels S; Caillou B; Schlumberger M; Bidart JM; Polak M
    J Clin Endocrinol Metab; 2007 Jan; 92(1):70-6. PubMed ID: 17077129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylation status of genes in papillary thyroid carcinoma.
    Smith JA; Fan CY; Zou C; Bodenner D; Kokoska MS
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1006-11. PubMed ID: 17938324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas.
    Gérard AC; Daumerie C; Mestdagh C; Gohy S; De Burbure C; Costagliola S; Miot F; Nollevaux MC; Denef JF; Rahier J; Franc B; De Vijlder JJ; Colin IM; Many MC
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4977-83. PubMed ID: 14557483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determining tissue origin of circulating epithelial cells (CEC) in patients with differentiated thyroid cancer by real-time PCR using thyroid mRNA probes.
    Sorg S; Pachmann K; Brede-Hekimian K; Freesmeyer M; Winkens T
    Cancer Lett; 2015 Jan; 356(2 Pt B):491-5. PubMed ID: 25304372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relapse.
    Barzon L; Boscaro M; Pacenti M; Taccaliti A; Palù G
    Int J Cancer; 2004 Jul; 110(6):914-20. PubMed ID: 15170676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.